Immune checkpoint inhibitors: here to stay.
| Autor: | Carvalho FM; Department of Pathology, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Estevez Diz MDP; Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Carvalho JP; Discipline of Gynecology and Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Translational cancer research [Transl Cancer Res] 2023 Oct 31; Vol. 12 (10), pp. 2438-2441. Date of Electronic Publication: 2023 Oct 20. |
| DOI: | 10.21037/tcr-23-1343 |
| Abstrakt: | Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-1343/coif). FMC reports receiving payments for lectures from GSK and MSD. The other authors have no conflicts of interest to declare. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|